Trial Evaluating Three Fixed Doses of Paliperidone Extended-Release (ER) Tablets and Olanzapine in the Treatment of Patients With Schizophrenia
Clinical trial NCT00083668 · COMPLETED
Trial details
- NCT number
- NCT00083668
- Sponsor
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2004-04-01
- Enrollment
- 619
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.